FeesSafety
Pluang+

Global gastric device market grows slowly to $134M by 2032 amid competition from drugs and surgery

Market News
22 Oct 2026
Globe News Wire
View Source
Neutral
Global gastric device market grows slowly to $134M by 2032 amid competition from drugs and surgery

The global gastric device market, valued at over $124 million in 2025, is projected to grow modestly to about $134 million by 2032, expanding at a 1.1% CAGR. Growth is limited due to competition from bariatric surgery and GLP-1 weight-loss drugs, which have reduced demand for gastric balloons and bands. Gastric balloons remain the dominant segment, favored for being less invasive and reversible, while gastric bands face decline due to complications and preference shifts. Manufacturers are repositioning devices as temporary or bridge therapies for patients not ready or eligible for surgery. Innovations like swallowable balloons may improve access, but surgical and drug treatments continue to dominate the obesity treatment market.

The global gastric device market outlook provides context for health-related sectors. For readers following health stocks, here is Pluang's market snapshot as of Oct 22, 2026 20:11 WIB: out of 150 priced US health-sector stocks, 67 rose and 77 fell. Notable movers include MRVI at USD 7.40 with a 1-day change of -2.25%, Moderna (MRNA) at USD 240.43 with a 1-day change of -2.19%, and Illumina (ILMN) at USD 277.51 with a 1-day change of -1.89%.

More News

Analyst sets $650 price target for Meta amid concerns over rising AI spending.

Analyst sets $650 price target for Meta amid concerns over rising AI spending.

Scotiabank analyst Nat Schindler set a $650 price target for Meta Platforms, about 6.8% below its then-current price of $697.52. Despite Meta's strong revenue from Facebook, Instagram, and WhatsApp, investor concerns over increased artificial intelli...

Analyst Insights
Bearish
37 minutes ago
UBS keeps Buy on Berkshire Hathaway amid strong cash reserves and strategic investments.

UBS keeps Buy on Berkshire Hathaway amid strong cash reserves and strategic investments.

UBS maintains a Buy rating on Berkshire Hathaway's Class A shares, currently trading near $811,320. The company's diverse portfolio and substantial cash reserves of about $360 billion provide stability and investment flexibility. Investor confidence ...

Analyst Insights
Bullish
41 minutes ago
Barclays misses Q3 earnings estimates despite 12% profit rise and £500M buyback plan

Barclays misses Q3 earnings estimates despite 12% profit rise and £500M buyback plan

Barclays PLC reported Q3 2026 earnings with EPS of $0.66 and revenue of $9.86 billion, both slightly below analyst estimates. Pre-tax profit rose 12% year-over-year to £2.32 billion but missed forecasts due to a 19% decline in fixed-income revenue, p...

Company Fundamentals
Bearish
46 minutes ago
Comfort Systems USA expects strong Q3 2026 growth with $12.85 EPS and $3.4B revenue forecast.

Comfort Systems USA expects strong Q3 2026 growth with $12.85 EPS and $3.4B revenue forecast.

Comfort Systems USA is set to report strong Q3 2026 results, with analysts predicting earnings of $12.85 per share and revenue around $3.40 billion, driven by high demand in data centers and a record $14.06 billion backlog. The company showed robust ...

Company Fundamentals
Bullish
52 minutes ago
Karman boosts AI compute by 60% at NexGen Cloud's Montreal data center using power orchestration tech

Karman boosts AI compute by 60% at NexGen Cloud's Montreal data center using power orchestration tech

Karman has enabled NexGen Cloud to increase AI compute capacity by 60% within the same power budget at its Montreal data center by using its AI-driven power orchestration platform. This technology allows 16 NVIDIA B300 servers to run within the power...

Market News
Bullish
52 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App